Mylan Laboratories Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Moxifloxacin Export Records India — #6 Exporter, 28 Shipments, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Mylan Laboratories Limited — Moxifloxacin Exporter #6 | $1.0M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #6 for Moxifloxacin · $1.0M export value · DGFT Verified

Mylan Laboratories Limited is the #6 Indian exporter of Moxifloxacin with $1.0M in export value and 28 verified shipments. Mylan Laboratories Limited holds a 3.1% market share in Moxifloxacin exports across 4 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Moxifloxacin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Moxifloxacin?

Country	Value	Shipments	Share
UNITED STATES	$831.4K	18	84.1%
FRANCE	$134.1K	4	13.6%
SPAIN	$11.9K	2	1.2%
NETHERLANDS	$10.9K	4	1.1%

Who Are the Top Buyers of Moxifloxacin from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN INSTITUTIONAL INC 2898	UNITED STATES	$742.1K	16
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$74.4K	2
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$59.7K	2
M/S..MYLAN INSTITUTIONAL INC	UNITED STATES	$44.7K	1
MYLAN INSTITUTIONAL INC	UNITED STATES	$44.6K	1
VIATRIS PHARMACEUTICALS S,L,U,	SPAIN	$11.9K	2
VIATRIS PHARMACEUTICALS SL,	NETHERLANDS	$10.9K	4

Mylan Laboratories Limited supplies Moxifloxacin to 7 buyers globally. The largest buyer is MYLAN INSTITUTIONAL INC 2898 (UNITED STATES), followed by CSP VIATRIS SANTE AT CSP- LAB, (FRANCE) and CSP MYLAN SAS AT CSP LABO 274 (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6	$335.7K	7
MOXIFLOXACIN TAB 400MG 7BL FR VIA (PACKS 1X7S BLISTER)(24798 PACKX X 1X7S=173586 NOS)	$50.0K	1
MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608639 TAX VAL 3952601.12	$47.6K	1
MOXIFLOXACIN HCL INJ1.6MG/ML 12S US SU67608639 TAX VAL 3952601.12	$47.6K	1
MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608711 TAX 3888726.19	$46.8K	1
MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU67608712 TAX 3866900.37	$46.5K	1
MOXIFLOXACIN HYDROCHLORIDE INSODIUM CHLORID INJECTION(400MG/250ML0.8%SALINE)(1.6MG/ML)12S MYLAN US(3234578)VAL3904915.76	$44.8K	1
MOXIFLOXACINHYDROCHLORIDE IN SODIUMCHLORIDE INJ400MG/250ML 0.8%SALINE 1.6MG/ML12SMYLANUS BNO:3234577 T-VALUE:3912238.29	$44.7K	1
MOXIFLOXACIN HCL INJ-1.6MG/ML-12S-US-SU6BATCH NO:7608625 TAXABLE VALUE:3720116.53	$44.6K	1
MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE INJECTION (400MG/250ML 0.8%SALINE)(1.6MG/ML)(12S)MYLANUS(3234513	$43.7K	1

Mylan Laboratories Limited exports 20 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MOXIFLOXACIN HCL INJ 1.6MG/ML 12S US SU6 with 7 shipments worth $335.7K.

How Does Mylan Laboratories Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	AJANTA PHARMA LIMITED	$1.4M	112	11	$12.4K
1	MACLEODS PHARMACEUTICALS LTD	$1.4M	27	14	$50.0K
6	MYLAN LABORATORIES LIMITED ★	$1.0M	28	4	$36.8K
7	AUROLAB TRUST	$806.3K	192	46	$4.2K
8	ALEMBIC PHARMACEUTICALS LIMITED	$683.8K	25	1	$27.4K

Mylan Laboratories Limited ranks #6 among 336 Indian Moxifloxacin exporters. Average shipment value of $36.8K compared to the market average of $42.4K. The closest competitors by value are AJANTA PHARMA LIMITED and MACLEODS PHARMACEUTICALS LTD.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Moxifloxacin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 28 individual customs records matching Mylan Laboratories Limited exporting Moxifloxacin, covering 20 formulations to 4 countries via 7 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Mylan Laboratories Limited — Moxifloxacin Exporter Profile

Mylan Laboratories Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from Mylan Laboratories Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Moxifloxacin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Moxifloxacin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from Mylan Laboratories Limited

Moxifloxacin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source